|
Market Closed -
NSE India S.E.
12:05:10 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,861.00 INR | -0.21% |
|
-2.87% | +8.22% |
| 09-09 | Sun Pharma Sets Up Global Treasury Center in India's GIFT City | MT |
| 09-09 | Sun Pharma Assigned Baa1, BBB+ Ratings by Moody's, S&P | MT |
| Market Cap | 4,475B 47.02B 40.46B 38.1B 34.72B 64.95B 65.21B 452B 175B 2,280B 177B 173B 7,222B | P/E 2027 * |
34.4x | P/E 2028 * | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4,204B 44.18B 38.02B 35.8B 32.62B 61.02B 61.27B 424B 164B 2,142B 166B 162B 6,785B | EV / Sales 2027 * |
6.46x | EV / Sales 2028 * | 5.67x |
| Free-Float |
44.39% | Yield 2027 * |
0.92% | Yield 2028 * | 1.07% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUNPHARMA | Delayed | |
Bombay S.E.
| SUNPHARMA | Delayed |
Last Transcript : Sun Pharmaceutical Industries Ltd.
| 1 day | -0.21% | ||
| 1 week | -2.87% | ||
| Current month | -6.24% | ||
| 1 month | -4.29% | ||
| 3 months | +4.18% | ||
| 6 months | +2.66% | ||
| Current year | +8.22% |
| 1 week | 1,840.5 |  | 1,917.3 |
| 1 month | 1,840.5 | | 1,984.8 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,548 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 31/08/2025 | |
| Director of Finance/CFO | 58 | 30/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 31/08/2025 | |
| Director/Board Member | 73 | 24/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -2.87% | +16.79% | +63.69% | 47.02B | |
| -1.80% | -6.33% | +37.87% | +114.34% | 39.94B | |
| -0.85% | -2.20% | +7.52% | +77.84% | 11.82B | |
| +0.75% | -1.53% | -12.18% | +10.10% | 11.57B | |
| +0.38% | +0.19% | +19.18% | +137.27% | 9.18B | |
| -0.40% | -5.88% | +34.57% | -17.80% | 7.2B | |
| -0.82% | -1.79% | +13.33% | +197.80% | 7.22B | |
| -0.08% | -1.87% | +25.07% | +33.65% | 7.32B | |
| +1.32% | +0.10% | -43.62% | +22.77% | 5.2B | |
| -0.41% | -0.03% | +35.71% | +103.65% | 4.64B | |
| Average | -0.21% | -1.90% | +13.42% | +74.33% | 15.11B | |
| Weighted average by Cap. | -0.56% | -2.93% | +19.15% | +79.44% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.84B 5.89B 5.54B 5.05B 9.45B 9.49B 65.7B 25.39B 332B 25.69B 25.13B 1,051B | 729B 7.66B 6.59B 6.21B 5.66B 10.58B 10.62B 73.57B 28.43B 371B 28.77B 28.14B 1,177B |
| Net income | 130B 1.36B 1.17B 1.1B 1.01B 1.88B 1.89B 13.09B 5.06B 66.06B 5.12B 5.01B 209B | 154B 1.61B 1.39B 1.31B 1.19B 2.23B 2.24B 15.51B 5.99B 78.27B 6.06B 5.93B 248B |
| Net Debt | -271B -2.84B -2.45B -2.3B -2.1B -3.93B -3.94B -27.31B -10.56B -138B -10.68B -10.45B -437B | -338B -3.56B -3.06B -2.88B -2.63B -4.91B -4.93B -34.15B -13.2B -172B -13.35B -13.06B -546B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | ₹1,861.00 | -0.21% | 1,178,648 |
| 09/09/26 | ₹1,864.90 | -1.11% | 1,396,896 |
| 08/09/26 | ₹1,885.90 | -0.48% | 1,422,627 |
| 07/09/26 | ₹1,895.00 | -0.21% | 1,579,345 |
| 04/09/26 | ₹1,899.00 | -0.89% | 761,333 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
